The IBN SINA Pharmaceutical Industry PLC reported earnings results for the second quarter and six months ended December 31, 2023. For the second quarter, the company reported sales was BDT 2,930.3 million compared to BDT 2,161.14 million a year ago. Net income was BDT 209.28 million compared to BDT 184.51 million a year ago. Basic earnings per share from continuing operations was BDT 6.7 compared to BDT 5.9 a year ago.
For the six months, sales was BDT 5,825.83 million compared to BDT 4,616.12 million a year ago. Net income was BDT 372.12 million compared to BDT 329.04 million a year ago. Basic earnings per share from continuing operations was BDT 11.92 compared to BDT 10.53 a year ago.